This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Henry Schein's CEO Discusses Q4 2011 Results - Earnings Call Transcript

Stanley M. Bergman

Thank you, Steven, very much for your update and I'd like to now provide a little bit color on the business units.

So let me begin with the North American Dental business. That's our dental business in the United States and in Canada. The results for our North American Dental business was strong across the board and reflects steady patient traffic to our Dental customers' offices and higher demand for dental equipment. Of course, this was partially driven by the tax incentives that were in effect for 2011.

Internal growth in sales of Dental consumable merchandise in local currencies was 4.8% during the quarter, excluding the extra week. So I think it's best to look at it excluding the extra week, which is solidly ahead of our estimate for the market growth and shows the strength of our Dental franchise here in the United States and in Canada. And our dental equipment results turned positive for the quarter with internal growth in local currencies at 3.8%. Again, if you should take out the extra week and this is after taking out the extra week. And as I noted during our last quarter call, we entered the fourth quarter with a strong backlog of equipment orders, including some that occurred in the -- early in the fourth quarter due to the timing of the end of the third quarter. I think we provided some color on this during the third quarter conference call.

So overall, I think we continue to be happy with our North American Dental businesses. They're doing well, gaining market share. The team has high morale and overall, the management is doing a very good job.

Read the rest of this transcript for free on

3 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,812.19 +19.51 0.11%
S&P 500 2,089.14 +2.55 0.12%
NASDAQ 5,102.8080 +0.33 0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs